Biodesix, Inc. BDSX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $96.1M+29.1% | $88.5M+24.1% | $80.17M+22.3% | $76.56M+25.7% | $74.46M+35.8% | ||
| $12.42M+19.5% | $12M+25.5% | $11.55M+27.8% | $11.1M+31.8% | $10.39M+18.4% | ||
| $91.36M+13.7% | $87.55M+8.8% | $84.79M+10.9% | $83.09M+15.5% | $80.34M+16.5% | ||
| $121.03M+13.0% | $116.37M+10.0% | $112.73M+12.4% | $110.65M+17.5% | $107.08M+17.9% | ||
| -$24.94M+23.5% | -$27.87M+19.2% | -$32.56M+6.2% | -$34.1M-2.4% | -$32.61M+9.4% | ||
| -26%+17.8pp | -31.5%+16.9pp | -40.6%+12.4pp | -44.5%+10.1pp | -43.8%+21.8pp | ||
| $8.01M+8.0% | $7.72M-6.6% | $7.41M-16.1% | $7.38M-19.7% | $7.41M-23.4% | ||
| -$7.02M+10.1% | -$7.39M+12.3% | -$6.98M+23.3% | -$6.98M+37.7% | -$7.81M+29.5% | ||
| -$31.96M+20.9% | -$35.27M+17.9% | -$39.54M+9.8% | -$41.08M+7.7% | -$40.42M+14.1% | ||
| -33.3%+21.0pp | -39.8%+20.3pp | -49.3%+17.5pp | -53.7%+19.4pp | -54.3%+31.5pp | ||
| -$2.48+38.5% | -$3.19-20.4% | -$3.79-122% | -$4.03-796% | -$4.03-646% | ||
| -$19.31M+28.0% | -$22.2M+22.7% | -$26.82M+8.8% | -$28.28M+1.5% | -$26.82M+16.3% | ||
| -20.1%+15.9pp | -25.1%+15.2pp | -33.5%+11.4pp | -36.9%+10.2pp | -36%+22.4pp | ||
| -$24.94M+23.5% | -$27.87M+19.2% | -$32.56M+6.2% | -$34.1M-2.4% | -$32.61M+9.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Biodesix, Inc.'s revenue?
- Biodesix, Inc. (BDSX) generated $96.1M in revenue over the trailing twelve months, up 29.0% year over year.
- Is Biodesix, Inc. profitable?
- Biodesix, Inc. is not currently profitable: it reported a net loss of $32.0M over the trailing twelve months, a -33.3% net margin.
- What is Biodesix, Inc.'s earnings per share?
- Biodesix, Inc.'s diluted EPS over the trailing twelve months is $-2.48.
- Where does Biodesix, Inc.'s income statement data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
